论文部分内容阅读
目的:探究诺舒治疗功能失调性子宫出血的临床疗效。方法:以中山市博爱医院2012年3月-2014年3月收治的45例功能失调性子宫出血患者为研究对象,均接受诺舒阻抗控制子宫内膜切除术治疗,术后随访1~12个月,统计手术情况(手术时间、术中出血量)及随访结果。结果:45例患者平均手术时间(88.5±7.5)s,术中出血量平均(8.2±1.0)m L,术后平均住院时间(1.0±0.3)d。随访1、3、6、12个月时闭经率分别为20.0%、33.3%、40.0%、60.0%,有效率分别为100.0%、93.3%、93.3%、95.6%。另外,随访12个月时,功血合并子宫腺肌病组与功血未合并子宫腺肌病组患者闭经率、有效率比较,差异具有统计学意义(P<0.05)。结论:诺舒治疗功能失调性子宫出血疗效明确,安全性高,术后恢复快,但可能受子宫腺肌病影响。
Objective: To investigate the clinical efficacy of Nosur in treating dysfunctional uterine bleeding. Methods: Forty-five patients with dysfunctional uterine bleeding who were admitted to Pok Oi Hospital of Zhongshan City from March 2012 to March 2014 were enrolled in this study. Patients receiving nausea resistance control endometrium resection were followed up for 1 to 12 months Month, statistics of surgical conditions (operation time, intraoperative blood loss) and follow-up results. Results: The mean operation time was (88.5 ± 7.5) s in 45 patients, the average amount of bleeding during operation was (8.2 ± 1.0) m L, and the average postoperative hospital stay was (1.0 ± 0.3) d. The menopausal rates at follow-up of 1, 3, 6 and 12 months were 20.0%, 33.3%, 40.0% and 60.0%, respectively. The effective rates were 100.0%, 93.3%, 93.3% and 95.6% respectively. In addition, at 12 months of follow-up, there was significant difference in the rate of menopause and effective rate between the patients with dysfunctional uterine bleeding and dysfunctional uterine adenomyosis (P <0.05). Conclusion: Nosur treatment of dysfunctional uterine bleeding is effective, safe and rapid after operation, but may be affected by adenomyosis.